1973•PubMedRequires access

[Lactation inhibition with chlormadinone and mestranol].

Z Pilawski, Diana A. Olszewska, Z Piernikowski, B Pronicki

Open publisher page 0 citations

Abstract

12 women were administered the contraceptive preparation Ovosiston which consists of 3 mg of chlormadinone and .1 mg of mestranol and another 132 were given Femigen-Polfa which contains 2 mg of chlormadinone acetate and .05 mg of mestranol. All subjects were administered 3 tablets daily in the first 2 periods decreasing to 2 tablets and finally 1 tablet until 25 days before the laying in. The level of lactation was measured throughout this period. The use of chlormadinone and mestranol was found to be an effective method of inhibiting and depressing lactation through its ability to liquidate secretions from the uterus. Femigen was found to be more swiftly acting than Ovosiston takin effect in 24 hours. Catamnesis showed that these preparations have a detrimental effect on subsequent menstrual cycles.

About this research paper

What this paper is about

12 women were administered the contraceptive preparation Ovosiston which consists of 3 mg of chlormadinone and .1 mg of mestranol and another 132 were given Femigen-Polfa which contains 2 mg of chlormadinone acetate and .05 mg of mestranol. All subjects were administered 3 tablets daily in the first 2 periods decreasing to 2 tablets and finally 1 tablet until 25 days before the laying in. The level of lactation was measured throughout this period. The use of chlormadinone and mestranol was found to be an effective method of inhibiting and depressing lactation through its ability to liquidate secretions from the uterus. Femigen was found to be more swiftly acting than Ovosiston takin effect in 24 hours. Catamnesis showed that these preparations have a detrimental effect on subsequent menstrual cycles.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

12 women were administered the contraceptive preparation Ovosiston which consists of 3 mg of chlormadinone and .1 mg of mestranol and another 132 were given Femigen-Polfa which contains 2 mg of chlormadinone acetate and .05 mg of mestranol. All subjects were administered 3 tablets daily in the first 2 periods decreasing to 2 tablets and finally 1 tablet until 25 days before the laying in. The level of lactation was measured throughout this period. The use of chlormadinone and mestranol was found to be an effective method of inhibiting and depressing lactation through its ability to liquidate secretions from the uterus. Femigen was found to be more swiftly acting than Ovosiston takin effect in 24 hours. Catamnesis showed that these preparations have a detrimental effect on subsequent menstrual cycles.

Key concepts: Chlormadinone acetate, Mestranol, Medicine, Lactation, Population, Internal medicine, Research methodology, Family planning

Related papers

Back to paper searchBrowse research topicsOriginal source
[Lactation inhibition with chlormadinone and mestranol]. — Research Paper | ScholarLens